Symbol Lookup

Tuesday September 27, 2016 4:36 PM ET. Data delayed 15 minutes.
0.00
0.00 (-7.69%)
Bid/Lots
0.00/100
Ask/Lots
0.00/2,475
Open/Prev Close
0.00/0.00
Day Range
0.00-0.00
52-Week Range
0.00-6.50
Vol/Avg Daily Vol
10.7M/11.7M
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
Guided Therapeutics Receives Order for 7 LuViva(R) Advanced Cervical Scans and 4,000 Disposable Cervical Guides for Indonesia
8:05AM ET on Wednesday Aug 31, 2016 by Business Wire

Guided Therapeutics, Inc. (OTCQB: GTHP), developer of the LuViva(R)Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care, today announced it has received an order f...

Company Information

Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices. The Company's primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The Company's technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The Company focuses on two primary applications for LuViva: first, as a cancer screening tool and second, as a triage. Its product, in addition to detecting the structural changes attributed to cervical cancer, is also detects the biochemical changes that precede the development of visual lesions. LuViva consists of three components: Touch screen monitor, Hand Held Unit (HHU) and the Wheeled Base.

CONTACT INFORMATION

Headquarters5835 Peachtree Cors E Ste D
NORCROSS, GA, United States 30092-3413
Phone770-242-8723
Fax770-242-8639

EXECUTIVE OFFICERS

Independent Chairman and DirectorMichael James
President, Chief Executive Officer and Acting Chief Financial OfficerGene Cartwright
Senior Vice President - EngineeringRichard Fowler
Independent DirectorJohn Imhoff
Independent DirectorJonathan Niloff

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$250.5KBeta0.27
Revenue (TTM)$743.0KEPS$-3.73
Shares Out.192.7MBook Value$-2.35
Guided Therapeutics Inc does not pay a dividend.P/E--
Price/Sales (TTM)0.3
P/Cash Flow (TTM)--
Operating Margin-728.13%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample